Searched for
SWISS PHARMACEUTICAL INDUSTRY
Issues related to India-EFTA trade pact implementation may figure during Piyush Goyal's Switzerland visitCommerce Minister Piyush Goyal visits Switzerland this week. He will discuss issues related to the India-EFTA free trade agreement. The agr...- India calls for deeper cooperation in R&D, biotech, pharma with SwitzerlandIndia is seeking enhanced collaboration with Switzerland in research, biotechnology, and pharmaceuticals. This move aims to bolster economi...
- US slashes tariffs to 15% for Switzerland after reaching trade deal, boost bilateral investmentThe US and Switzerland have agreed to a framework reducing US tariffs on Swiss goods from 39% to 15%. This deal includes a $200 billion Swi...
- Trump’s tariffs push Switzerland to the Brink - 100,000 Swiss jobs on the chopping blockSwiss job losses due to Trump tariffs: The United States has imposed tariffs on Swiss exports due to the trade deficit. This move has put s...
- Indian pharma firms not copying products, India respect IP rights, says GoyalCommerce and Industry Minister Piyush Goyal refuted claims that Indian pharmaceutical firms copy Swiss products, calling it a long-standing...
- 16 years in the making, key details of India's pact with four-nation European trade blocIndia signed a free trade pact with Switzerland, Norway, Iceland, and Liechtenstein, committing to reduce tariffs and receive $100 billion ...
- Union Minister Piyush Goyal discusses progress of FTA negotiations during meeting with EFTA delegationUnion Commerce and Industry Minister Piyush Goyal held a meeting with the European Free Trade Association (EFTA) delegation led by Swiss St...
- Pharma companies must adhere to marketing norms during conferences: GovtAsking the lobbies to ensure that no unethical promotion of pharma products is done during conferences, it said companies must adhere to th...
- Lara Bezerra to take over as Roche Products India MDLara has over 24 years of experience in the pharmaceutical industry and was earlier the general manager of Roche Venezuela.
- Cipla, Novartis explore marketing tie-upCipla lost its battle with Novartis in March, when the Delhi High Court stayed the company’s request to sell copies of Novartis respiratory...
- Talks on India-European Free Trade Association pact stuck over IPR issuesAccording to the Ministry of Commerce data, India's exports to Switzerland was USD 1.8 billion in 2013-14 and imports were USD 19.3 billion...
- SIX Swiss Exchange eyes life sciences companies for listingLeading European bourse SIX Swiss Exchange is wooing Indian industrial and life sciences companies to get listed on its platform.
- Novartis revamps pharma world with mega-deals with GSK, Eli LillyThe Swiss drugmaker said it would divest its vaccines business, excluding flu, to GSK for $7.1 million plus royalties.
- Individual cases to dictate MNC drug cos’ approach to patentsRoche’s decision to give up India patent for Herceptin unlikely to set a precedent, says MNC drug companies’ body.
- Indo-Swiss trade expands from US$7.03 bn in 2005-06 to US$15.3 bn in 2009-10, more than doubling in 5 yearsThe two-way trade expanded from US$7.03 billion in 2005-06 to US$15.3 billion in 2009-10, that is, more than doubling in 5 years.
- Hetero bags UAE deal for swine flu drugThe United Arab Emirates’ health ministry has given approval to Neopharma to manufacture a version of flu drug Tamiflu in a joint venture w...
- Switzerland offers varied benefits: WeltiAmbassador of Switzerland to India Philippe Welti spoke on the benefits of investing in Switzerland.
- Roche seals $47-b Genentech dealSwiss pharmaceutical giant Roche agreed to pay $46.8 billion to buy the 44% of biotech pioneer Genentech that it doesn’t already own, endin...
- 'Indian IT experts are welcome'Doris Leuthard speaks about a number of sectors ranging from pharmaceuticals and agriculture to banking.
- Indo-Swiss pact on IPRs on anvilIndia is likely to sign an agreement with Switzerland on intellectual property rights (IPRs) to improve the bilateral economic cooperation ...
Load More
